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Innate immune response is the first line of antiviral defense resulting, in most cases, in pathogen clearance with minimal clinical
consequences. Viruses have developed diverse strategies to subvert host defense mechanisms and increase their survival. In the
transmissible gastroenteritis virus (TGEV) as a model, we previously reported that accessory gene 7 counteracts the host antivi-
ral response by associating with the catalytic subunit of protein phosphatase 1 (PP1c). In the present work, the effect of the ab-
sence of gene 7 on the host cell, during infection, was further analyzed by transcriptomic analysis. The pattern of gene expression
of cells infected with a recombinant mutant TGEV, lacking gene 7 expression (rTGEV-7), was compared to that of cells infected
with the parental virus (rTGEV-wt). Genes involved in the immune response, the interferon response, and inflammation were
upregulated during TGEV infection in the absence of gene 7. An exacerbated innate immune response during infection with
rTGEV-7 virus was observed both in vitro and in vivo. An increase in macrophage recruitment and activation in lung tissues
infected with rTGEV-7 virus was observed compared to cells infected with the parental virus. In summary, the absence of pro-
tein 7 both in vitro and in vivo led to increased proinflammatory responses and acute tissue damage after infection. In a porcine
animal model, which is immunologically similar to humans, we present a novel example of how viral proteins counteract host
antiviral pathways to determine the infection outcome and pathogenesis.
The order Nidovirales comprises enveloped single-stranded,positive-sense RNA viruses and includes the Coronaviridae
family, which comprises viruses with the largest known RNA ge-
nome (30 kb) (1, 2). Coronaviruses (CoVs) have been classified
into three genera—Alphacoronavirus, Betacoronavirus, and Gam-
macoronavirus (3)—and a fourth, recently proposed, Deltacoro-
navirus genus (3, 4). These viruses are the causative agents of a
variety of human and animal diseases. In humans, CoVs produce
respiratory tract infections, ranging from the common cold to
severe pneumonia and acute respiratory distress syndrome
(ARDS) that may result in death (5–9). In animals, CoVs also
cause life-threatening diseases, such as severe enteric and respira-
tory tract infections, and are economically important pathogens
(10). However, there is only limited information on themolecular
mechanisms governing CoV virulence and pathogenesis.
The 5= two-thirds of the CoV genome encode the replicase
proteins that are expressed from two overlapping open reading
frames (ORFs) 1a and 1b (11). The 3= third of the genome contains
the genes encoding structural proteins and a set of accessory genes,
whose sequence and number differ between the different species
of CoV (1, 3). Generally, CoV accessory genes have been related
with virulencemodulation (12). Severe and acute respiratory syn-
drome (SARS)-CoV contains the largest number of accessory
genes, and it has been proposed that these genes could be respon-
sible for its high virulence (13, 14). A role for some structural
genes, such as SARS-CoV genes E and 6, onCoVpathogenesis and
virulence has also been demonstrated (14–18). Nevertheless, in
general, the function of accessory genes during CoV infection re-
quires further studies (13, 14).
Double-stranded RNA (dsRNA), produced by RNA viruses as
a replication intermediate, is a pathogen-associated molecular
pattern thatmediates the activation of well-characterized antiviral
mechanisms leading to protein synthesis shut down and the stim-
ulation of host innate immunity for initial detection of pathogens
and subsequent activation of adaptive immunity (19). The path-
way that leads to a block in protein synthesis includes the activa-
tion of double-stranded RNA-dependent protein kinase (PKR),
leading to eukaryotic translation initiation factor 2 (eIF2) phos-
phorylation, and the activation of the 2=-5=-oligoadenylate syn-
thetase (2=-5=OAS) and its effector enzyme, the RNase L (RNase
L), responsible for RNA degradation (19, 20). The host immune
response triggered by dsRNA is a key component of the innate
immunity and involves activation of both proinflammatory cyto-
kines and the type I interferon (IFN) system (21, 22).
There are three main cellular receptors for the detection of
dsRNA: Toll-like receptor 3 (TLR3), retinoic acid-inducible gene
I (RIG-I), and melanoma differentiation-associated gene 5
(MDA5) (22). TLR3 is located in the endosomal membrane of
antigen-presenting cells, while the cytoplasmic sensors RIG-I and
MDA5 are the main receptors for viral dsRNA in most cell types
(20). Recently, degradation of host RNAbyRNase Lwas proposed
to be an amplifier of the innate immune response by increasing the
amount of ligand involved in RIG-I and MDA5 recognition (23,
24). The signaling pathways activated by RIG-I or MDA5 recog-
nition of dsRNA mainly lead to the activation of transcription
factors IRF3/7 andNF-B that induce the expression of type I IFN
and proinflammatory cytokines (25). This innate immune re-
sponse must be tightly regulated, since there is only a fine line
separating the induction of a protective antiviral response and an
exaggerated inflammatory response that can lead to immunopa-
thology (26).
Due to the deleterious effects of this response on virus sur-
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vival, many viruses have developed different strategies that
counteract the host antiviral responses triggered by dsRNA
(27). Many of the virus-encoded proteins with this activity
identified to date interfere with multiple steps of the innate
response. In addition, some viruses encode more than one gene
modulating innate immunity (27). CoVs are not an exception
and encode several proteins affecting type I IFN and proinflam-
matory cytokines production. Structural proteins, such as nu-
cleocapsid (N) protein from several CoVs, or SARS-CoVmem-
brane (M) protein have IFN antagonist activity (28–31). The
modulation of innate immune response by CoV nonstructural
protein 1 (nsp1), nsp3, and nsp16 has also been described.
Nsp1 acts by promoting RNA degradation and host proteins
synthesis suppression (32, 33), reducing both IFN production
and signaling (34, 35). The antagonist effect of nsp3 is con-
served in different CoV genera and affects IFN and proinflam-
matory cytokine production, although the mechanism of nsp3
action has not been determined in all cases (36–39). The IFN
antagonist effect of nsp16 was recently described, involving a
mechanism mediated by MDA5 recognition of non-self RNA
(40). As described above, CoV accessory genes have also been
related to virulence modulation. Therefore, it could be ex-
pected that some of these genes have a role in innate immunity.
To date, mouse hepatitis virus (MHV) ns2, 5a, and SARS-CoV
3b and 6 proteins have been reported as IFN antagonists (28,
41, 42). Although in general the mechanisms used by accessory
genes to interfere with the IFN response are not well character-
ized, SARS-CoV protein 6 has been studied in detail. This viral
protein antagonizes both IFN production (28) and signaling by
inhibiting signal transduction and activator of transcription 1
(STAT1) translocation to the nucleus (43). Further, it was re-
cently reported that MHV ns2 protein acts as a 2=-5=-phos-
phodiesterase that reduces the amount of 2=-5=-oligoadeny-
lates, avoiding the activation of RNase L and, as a consequence,
reducing RNA degradation during viral infection and type I
IFN production (24).
Transmissible gastroenteritis virus (TGEV) is an Alphacorona-
virus that contains three accessory genes: 3a, 3b, and 7 (44–46).
TGEV gene 7 is located at the 3= end of the genome and is the last
ORF. We have recently demonstrated that TGEV protein 7 coun-
teracts host antiviral response and influences virus pathogenesis
(47). TGEV protein 7 reduces both eIF2 phosphorylation and
cellular RNA degradation by RNase L (47). The mechanism of
TGEV protein 7 action is dependent on its binding to cellular
protein phosphatase 1 (PP1) (47). In addition, infection with a
mutant virus lacking gene 7 expression (rTGEV-7) results in
increased pathological damage compared to the parental (rTGEV-
wt) virus (47).
In this work, to understand themolecularmechanisms leading
to the increased rTGEV-7 pathogenesis, the role of protein 7 on
the host cell has been further analyzed by studying differential
patterns of gene expression during infection with either the wild-
type or mutant virus. An enhanced proinflammatory response
was observed in the absence of protein 7, both in vitro and in vivo.
This increased proinflammatory gene expression was associated
with elevated levels of macrophage recruitment and activation in
the infected tissues, being, at least in part, the cause for the en-
hanced tissue damage caused by viral infection in the absence of
protein 7.
MATERIALS AND METHODS
Ethics statement. All animal samples used in the present study were de-
rived from previously published in vivo experiments (47). As stated in the
previous publication, these experiments were performed in strict accor-
dance with EU (2010/63/UE) and Spanish (RD 1201/2005 and 32/2007)
guidelines.
Virus and cells. Swine testis (ST) cells were grown in Dulbecco mod-
ified Eagle medium supplemented with 10% fetal bovine serum (48). Re-
combinant TGEVs, both parental (rTGEV-wt) andmutant strains lacking
gene 7 expression (rTGEV-7), were grown and titrated as previously
described (47).
Microarray analysis. One day after achieving confluence, ST cells,
grown on 35-mm-diameter plates, were mock infected or infected at an
MOI of 5 with rTGEV-wt or rTGEV-7. To decrease sample variability,
nine independent infections were performed in each case. Samples of
culture supernatants were collected for virus titration as previously de-
scribed (47). Total RNA was extracted, at 6 and 12 hpi, using an RNeasy
minikit (Qiagen) according to the manufacturer’s instructions. RNAs
were pooled three by three, obtaining three biological replicates for each
experimental condition, andRNA integritywasmeasured in a bioanalyzer
(Agilent Technologies). RNAs were biotin labeled using a One Cycle Tar-
get labeling kit (Affymetrix). Briefly, cDNA was synthesized from 5 g of
total RNA using an oligo(dT) primer with a T7 RNA polymerase pro-
moter site added to the 5= end. After a second strand synthesis, in vitro
transcription was performed using T7 RNA polymerase to produce bio-
tin-labeled cRNA. cRNA preparations (15 g) were fragmented at 94°C
for 35 min into sections of 35 to 200 bases in length and added to a
hybridization solution (100 mM 4-morpholinopropanosulfonate acid, 1
M Na, 20 mM EDTA, 0.01% Tween 20). The cRNAs (10 g) were hy-
bridized to Genechip Porcine Genome Arrays (Affymetrix) at 45°C for 16
h. The arrays were stained with streptavidin-phycoerythrin and read at
1.56 m in a GeneChip Scanner 3000 7G System (Affymetrix). Indepen-
dent microarrays were hybridized for each sample.
Microarray data analysis. A robust multi-array analysis (RMA) algo-
rithm was used for background correction, normalization, and presenta-
tion of the expression levels (49). Analysis of differential expression was
performed using a Bayes moderated t test (limma) (50). P values were
corrected for multiple testing using the Benjamini-Hochberg method
(false discovery rate [FDR]) (51). The bioconductor packages “affy” and
“limma” (www.bioconductor.org) were used for these calculations. Due
to the poor Affymetrix porcine genome array annotation, an alternative
one based on porcine and human gene homology was used (52). Genes
were considered differentially expressed when FDR  0.05. In addition,
only geneswith a fold change of2 or of	2were considered for further
analysis.
Functional analysis ofmicroarray results.To understand the biolog-
ical significance underlying the gene expression data, further analysis was
performed. DAVID (53, 54) was used for the analysis of enriched Gene
Ontology (55) “biological process” terms in the groups of up- or down-
regulated genes.
RNA analysis by quantitative reverse transcription-PCR (RT-
qPCR). One day after confluence, ST cells, grown on 35-mm-diameter
plates, were infected at a multiplicity of infection (MOI) of 5. The total
intracellular RNA was extracted at different hours postinfection (hpi)
using the RNeasy minikit (Qiagen), according to the manufacturer’s in-
structions. Viral genomic RNA (gRNA) was evaluated by RT-qPCR anal-
ysis, using a custom TaqMan assay and following standard procedures set
up in our laboratory (56). Cellular gene expression was analyzed using
TaqMan gene expression assays (Applied Biosystems) specific for porcine
genes (Table 1). The 
-glucuronidase (GUSB) gene was selected as a ref-
erence (housekeeping) gene since its expression remains constant in in-
fected cells (independently of the rTGEV used) compared to noninfected
cells. Therefore, the expression levels of each gene were corrected by the
amount of housekeeping gene in each condition. The data were acquired
with an ABI Prism 7000 sequence detection system and analyzed with ABI
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Prism 7000 SDS version 1.2.3 software (Applied Biosystems). All experi-
ments and data analysis were MIQE compliant (57).
PBMC isolation and cytokine analysis. Lung, blood, and serum sam-
ples were obtained from infected animals (47). Two- to three-day-old
non-colostrum-deprived piglets, born from TGEV seronegative sows,
were inoculated with respiratory tropism recombinant viruses (107 PFU/
pig) according to standard procedures (58). Briefly, animals were infected
by two different routes (oral and intranasal) in combination. Infected
animals weremonitored daily to detect symptoms of disease and death. At
0.5, 1, 2, 3, 4, and 5 days postinfection (dpi) two animals per group were
sacrificed, and the samples were collected. Porcine peripheral blood
mononuclear cells (PBMCs) were isolated from 8ml of fresh heparinized
venous blood by density gradient centrifugation through a Histopaque-
1077 (Sigma-Aldrich) gradient according to the manufacturer’s recom-
mendations and kept frozen until their use. For their restimulation in
vitro, PBMCs were cultured (106 cells/well) in 24-well plates using RPMI
medium supplemented with 20% heat-inactivated fetal calf serum (FCS),
2 mM glutamine, 100 M nonessential amino acids, and 100 U of peni-
cillin-streptomycin/ml. After 18 h, purified TGEV (10 g/ml) was added
for stimulation, and 24 h after stimulation, total RNAwas extracted. RNA
extraction andRT-qPCRmeasurement of cellular genes was performed as
described above.
Cytokine expression analysis from lung samples. At different times
postinfection, lung sections from infected animals (47) were collected and
stabilizedwith RNAlater stabilization reagent (Life Technologies) accord-
ing to the manufacturer’s instructions. Total RNA was extracted by using
an RNeasy minikit (Qiagen) according to the manufacturer’s instruc-
tions. RT-qPCR measurement of viral gRNA and cellular mRNAs was
performed as described above.
Enzyme-linked immunosorbent assay (ELISA). ST cells were in-
fected at an MOI of 5, and the culture medium was harvested at 16 hpi.
Porcine tumor necrosis factor (TNF), CCL2 and IFN-
 protein levels
were estimated using Swine TNF ELISA kit (Invitrogen), Swine CCL2
VetSet ELISA development kit (Kingfisher Biotech), and a Pig IFNB
ELISA kit (Cusabio) according to the manufacturer’s instructions. The
data were collected from three independent infections. In addition, CCL2
and TNF were also measured in serum samples according to the manu-
facturer’s recommendations.
Immunofluorescence of fixed tissues.Representative sections of lung
tissue were fixed with 4% paraformaldehyde and stored in 70% ethanol at
4°C (47). Paraffin embedding and sectioning were performed by the his-
tology service in the National Center of Biotechnology (CNB-CSIC;
Spain). Sections (4 m) were deparaffined at 60°C and rehydrated by
successive incubations in 100% xylol, 100% ethanol, and 96% ethanol. To
unmask the antigens, tissue sections were boiled in citrate buffer (8.2 mM
sodium citrate; 1.8 mM citric acid; pH 6.5) for 5 min for macrophage
detection. Antigen unmasking for granulocyte detection was performed
by sample incubation with 0.05% trypsin-EDTA for 30min at 37°C. In all
cases, after antigen unmasking, the samples were permeabilized with
0.25% Triton X-100 in phosphate-buffered saline (PBS) for 15 min and
then blocked with 10% bovine serum albumin (BSA) and 0.25% Triton
X-100 in PBS for 30 min. The samples were incubated with a monoclonal
antibody that, in porcine lung samples, is specific for macrophages (4E9
[kindly provided by J. Dominguez], 1:100) (59), a monoclonal antibody
that, in porcine samples (60), is specific for granulocytes (Mac387 [Dako],
undiluted), or a rabbit polyclonal antibody specific for TGEV (1:100).
Bound primary antibodies were detected with Alexa Fluor 488-conju-
gated antibody specific for mouse (Invitrogen, 1:250) or Alexa Fluor 594-
conjugated antibody specific for rabbit (Invitrogen, 1:250), respectively.
Cell nuclei were stained with DAPI (4=,6=-diamidino-2-phenylindole
[Sigma], 1:200). Tissues were mounted in Prolong Gold antifade reagent
(Invitrogen) and analyzed with a confocal fluorescence microscope (TCS
SP5; Leica). Quantitative analysis of samples was performed with Meta-
Morph software. Positive pixels for leukocytes were calculated relative to
positive pixels for TGEV infection.
Statistic analysis. Two-tailed, unpaired Student t tests were used to
analyze difference in mean values between groups. All results were ex-
pressed as means  the standard deviations of the means. P values of
0.05 were considered significant.
RESULTS
Effect of protein 7 absence on host gene expression. To analyze
the impact of TGEV protein 7 on host gene expression during infec-
tion, the transcriptomes of rTGEV-wt- and rTGEV-7-infected cells
were compared, using porcine microarrays, at two points postinfec-
tion. It is worth noting that under the experimental conditions used
here (see Materials and Methods), both for the rTGEV-wt and
rTGEV-7 viruses, 99%of the cells were infected, and no differences
in virus titers were observed, as expected (47). MIAME-compliant
resultsof themicroarrayshavebeendeposited in theGeneExpression
Omnibus database (GEO [National Center for Biotechnology Infor-
mation], accession codeGSE41756). To select genes expressed at sig-
nificantly different levels in cells infected with either the wild-type or
mutant viruses, the threshold was established at a fold change of2
or	2 and a false discovery rate (FDR) of0.05 (Fig. 1A). A com-
parison of infected to noninfected cells, at late times postinfection,
showed more than 1,500 and 2,500 genes whose expression varied
significantly between rTGEV-wt and rTGEV-7 infection (Table 2).
In contrast, the number of differentially expressed genes was signifi-
cantly reduced when the transcriptomes of cells infected with
TGEV-wt and TGEV-7 were compared (Table 2). In relation to
rTGEV-wt-infected cells, 26 and 301 genes were upregulated, and 84
and 466 genes were downregulated at 6 and 12 h postinfection (hpi),
respectively, in rTGEV-7-infected cells. More than 60% of the dif-
ferentially expressedgenes at 6hpi also changed their expressionat 12
hpi. These results indicated that differential gene activation during
rTGEV-7 infection, compared to that induced by rTGEV-wt, was
maintained at 12 hpi, although additional differentially expressed
genes were noted at later times postinfection.
Genes differentially expressed during TGEV infection (both
up- and downregulated), in the presence or absence of protein 7,
TABLE 1 TaqMan assays
Genea Assay IDb Description
CCL2 (MCP1) Ss03394377_m1 C-C motif chemokine 2
CCL4 (MIP1B) Ss03381395_u1 C-C motif chemokine 4
CCL5 (RANTES) Ss03648940_m1 C-C motif chemokine 5
CXCL9 Ss03390033_m1 C-X-C motif chemokine 9
CXCL11 Ss03648935_g1 C-X-C motif chemokine 11
DDX58 (RIG-I) Ss03381552_u1 DEAD box protein 58
GUSB Ss03387751_u1 
-Glucuronidase
IFNB1 Ss03378485_u1 Interferon beta
IL-15 Ss03394854_m1 Interleukin 15
IRF1 Ss03388785_m1 Interferon regulatory factor 1
JAK2 Ss03394066_m1 Janus kinase 2
STAT1 Ss03392296_m1 Signal transducer and activator of
transcription 1
STAT5A Ss03394621_m1 Signal transducer and activator of
transcription 5A
TGFB1 Ss03382325_u1 Transforming growth factor 
1
TNF Ss03391318_g1 Tumor necrosis factor
TNFRSF5 (CD40) Ss03394339_m1 TNF receptor superfamily member 5
VCAM1 Ss03390912_m1 Vascular cell adhesion protein 1
a Alternative gene names are indicated in parentheses.
b TaqMan assays were used to measure porcine cellular gene expression by RT-qPCR.
ID, identifier. The “Ss” in these terms refers to Sus scrofa.
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FIG 1 Effect of TGEV protein 7 on host gene expression. (A) Comparison of gene expression in ST cells at 6 and 12 hpi usingmicroarrays. The data visualization and
threshold set up for results filtering were performed with FIESTA viewer (J. C. Oliveros, 2007, http://bioinfogp.cnb.csic.es/tools/FIESTA/index.php). The graphs
represent the normalized ratios for rTGEV-wt-infected versus mock-infected cells, rTGEV-7-infected versus mock-infected cells, and rTGEV-7-infected versus
rTGEV-wt-infected cells. Dark gray spots indicate upregulated probes (fold change,2), while medium gray spots indicate downregulated ones (fold change,	2).
Only genes with an FDR of0.05 were considered as candidate genes. (B) Candidate genes that were differentially expressed in rTGEV-7-infected cells compared to
rTGEV-wt-infected ones, at 12 hpi, were grouped with reference to their GO biological process terms. Numbers on the x axis indicate DAVID FDR values.
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were grouped, using DAVID software (53, 54), according to the
biological processes in which they could be potentially involved.
Most of the genes were associated with responses against viruses,
host defense response, and immune response (Fig. 1B) and there
was significant overlap among the genes of these three groups. The
genes included in response to virus gene ontology (GO) group
mainly affected the immune response, the IFN response, and in-
flammation, andmost of themwere significantly upregulated dur-
ing rTGEV-7 infection compared to that by rTGEV-wt (Fig. 2A).
Interestingly, analysis of the expression patterns during rTGEV-wt
and rTGEV-7 infections showed that, in general, genes activated
during rTGEV-wt infection were also activated during rTGEV-7
infection, although earlier or to a higher level than in rTGEV-wt in-
TABLE 2 Analysis of host gene expression using porcine microarrays
Comparison
Time point
(hpi)
No. of probesa
Upregulated Downregulated
WT vs Mock 6 373 148
12 1,119 768
7 vs Mock 6 289 127
12 1,259 1,782
7 vs WT 6 31 (26) 98 (84)
12 346 (301) 525 (466)
a Numbers in parentheses represent the numbers of different genes, since one gene
could be present in the array with more than one probe. Upregulated, fold change 2,
FDR 0.05; downregulated, fold change	2, FDR 0.05.
FIG 2 Host genes differentially expressed in rTGEV-7 versus rTGEV-wt-infected cells. (A) Candidate genes included in response to virus GO group were
classified according to their main biological functions. Black and gray lettering is used to indicate up- and downregulated genes, respectively. The numbers
indicate the fold change for each gene. For genes recognized with more than one probe, the value corresponding to the greatest up- or downregulation is
represented. (B) Thirteen candidate gene mRNAs were evaluated by RT-qPCR using specific TaqMan assays. RNA was extracted from rTGEV-wt- or rTGEV-
7-infected cells at 12 hpi. Gray bars represent the fold change obtained frommicroarray data. Black bars represent the data obtained byRT-qPCR.GUSBmRNA
levels were used as an endogenous control in all cases. Error bars indicate the standard deviations from three independent experiments. Imm. Resp., immune
response; Trans., transcription.
Cruz et al.
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fection (data not shown). Several genes from each group were se-
lected for RT-qPCR analysis, taking into account the availability of
TaqMan assays for porcine genes detection. In all cases, RT-qPCR
results confirmed the microarray results, validating the effects ob-
served in the microarray analysis (Fig. 2B). Altogether, these data
suggested that host innate immune response triggered by TGEV in-
fection was magnified in the absence of protein 7.
Effect of protein 7 absence on innate immunity gene expres-
sion. We have previously shown that, due to protein 7 absence,
rTGEV-7 infection promoted an intensified host dsRNA-in-
duced antiviral response (47). Taking this observation into ac-
count, a set of nine differentially expressed candidate genes in-
volved in innate immunity (Table 3) was selected to study their
expression kinetics by RT-qPCR. To discard a general transcrip-
tion upregulation during rTGEV-7 infection, which could affect
the expression of all cellular genes, the mRNA levels of two other
genes involved in immune response, such as JAK2 and transform-
ing growth factor 
 (TGF-
), were also evaluated as controls. No
differences in virus titers (data not shown) or viral gRNA accumu-
lation (Fig. 3) were observed between the parental and mutant
viruses, as expected (47). All of the selected candidate genes in-
creased their expression during TGEV infection (Fig. 3). Interest-
ingly, all of them were significantly upregulated in cells infected
with rTGEV-7, in comparison to cells infected with rTGEV-wt
(Fig. 3). In contrast, control genes JAK2 and TGF-
 were not
differentially expressed in the absence or presence of TGEV pro-
tein 7 (Fig. 3), indicating that the increased expression of candi-
date genes during rTGEV-7 infection was not the consequence
of a general induction of host transcription.
To confirm that the elevated mRNA levels correlated with an
increased protein accumulation, and attending to the availability
of assays for the specific detection of porcine proteins, the levels of
three cytokines (TNF, CCL2, and IFN-
) were measured during
TGEV infection. TNF, CCL2, and IFN-
 levels were quantified in
the medium of infected ST cells using commercial ELISAs. Cells
infected with rTGEV-7 virus secreted higher levels (Fig. 4) of
TNF (upper panels), CCL2 (medium panels) and IFN-
 (lower
panels) compared to rTGEV-wt-infected cells. Altogether, the
data confirmed the correlation between mRNA and protein ex-
pression levels of innate immunity genes induced by rTGEV in-
fection.
In vivo expression of proinflammatory cytokines in the ab-
sence of TGEV protein 7. It was previously shown that lung dam-
age in rTGEV-7-infected pigs was greater than that observed in
rTGEV-wt-infected animals (47). The observed lesions could be
correlated with acute inflammation in the infected tissue (26). As
described above, the data obtained in tissue culture indicate that
rTGEV-7 infection led to an increased expression of innate im-
munity-related genes, in particular of proinflammatory cytokines.
To analyze whether this was also the case in vivo, cytokine expres-
sion in PBMCs from infected animals was studied by RT-qPCR.
After in vitro restimulation of PBMCs from rTGEV-wt- and
rTGEV-7-infected animals with purified TGEV, an increase in
the expression of several proinflammatory cytokines, such as
TNF, CCL2, CCL5, and CXCL11, was observed (Fig. 5). TGEV
infection of PBMCswas not observed, in contrast towhat has been
previously described, indicating that TGEV could infect pDCs
(61–63). This cell type represents ca. 0.5% of the cells in a PBMC
preparation (64), and pDC enrichment methods are required for
the significant detection of TNF and type I IFN production by this
cell type (62). Therefore, the observed increase in proinflamma-
tory cytokines production was most likely due to re-exposure to
TGEV. The levels of cytokinemRNAswere higher in PBMCs from
rTGEV-7-infected animals than in those from rTGEV-wt-in-
fected animals (Fig. 5), in agreement with the results obtained in
tissue culture. These data strongly suggested that rTGEV-7 virus
also induced a higher expression of proinflammatory cytokines in
vivo.
To further analyze the proinflammatory cytokine levels in the
infected animals, mRNA levels in lung samples were measured by
RT-qPCR. Since the infection extent in the different lung sections
was different, viral gRNAwas also quantified, and cytokinemRNA
levels were related to viral gRNA levels (Fig. 6). At 1 dpi, the
mRNA levels of TNF, CCL2, and CCL5 were higher in rTGEV-
7-infected lungs than in rTGEV-wt-infected lungs (Fig. 6). In
the case of CCL2, this increase was also found at 2 dpi (Fig. 6,
middle panel). Moreover, CCL2 and TNF protein levels were
measured in the sera from infected animals. Sera from rTGEV-
7-infected animals contained higher levels of these cytokines
than those from rTGEV-wt-infected animals, particularly at early
dpi (Fig. 7). Altogether, the data indicated that rTGEV-7 virus
also induced an exacerbated proinflammatory response in vivo.
TABLE 3 Candidate genes selected for further studya
Immune category Cytokine Function Fold change
Innate immunity IFN-
 Antiviral, increased MHC class I expression 24.3
Th1 response IL-15 Stimulates growth and proliferation of T and NK cells 4.5
TNF Local inflammation, endothelial activation; stimulates cell proliferation and induces cell differentiation 6.8
CXCL9 Chemotactic for activated T cells; affects the growth, movement, or activation state of cells
participating in immune and inflammatory responses
3.2
CXCL11 Chemotactic for interleukin-activated T cells; role in diseases involving T-cell recruitment 6.7
Chemokine CCL2 Attracts monocytes and basophils; related to diseases characterized by monocytic infiltrates 7.9
CCL4 Inflammatory and chemokinetic properties 5.1
CCL5 Attracts monocytes, memory T-helper cells, and eosinophils; causes the release of histamine from
basophils and activates eosinophils
2.6
Others VCAM1 Important in cell-cell recognition; influences leukocyte-endothelial cell adhesion 2.7
Negative controls TGFB1 Controls proliferation, differentiation, and other functions in many cell types –1.15
JAK2 Mediates essential signaling events in both innate and adaptive immunity 1.67
a The selection was based on their differential expression levels and porcine TaqMan assay availability.
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FIG 3 Expression kinetics of host genes involved in inflammation. Nine candidate genes involved in inflammation and innate immunity were selected for
analysis of their expression kinetics by RT-qPCR. ST cells were infected with rTGEV-wt or rTGEV-7, and the total RNA was extracted at the indicated time
points. As a control for rTGEV replication, the viral gRNA levels were also evaluated. TGF-
 and JAK2were selected as negative control genes that did not change
their expression levels in rTGEV-7-infected cells compared to rTGEV-wt-infected cells. GUSB mRNA levels were used as an endogenous control in all cases.
Error bars indicate the standard deviations from three independent experiments. **, P 0.01; *, P 0.05.
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The expression of proinflammatory cytokines during infection
could lead to an enhancement of tissue damage due to the activa-
tion and recruitment of leukocytes, particularlymacrophages and,
in some infections, neutrophils (65). These activated cells may
amplify the damage produced by the pathogen, since they secrete
proinflammatory cytokines potentially involved in host-mediated
immunopathology (65, 66). To test this possibility, the presence of
granulocytes and macrophages in the lungs of rTGEV-wt- and
rTGEV-7-infected animals at 1 and 4 dpi was evaluated by im-
munofluorescence. At 1 dpi, an increase in granulocytes was ob-
served in both rTGEV-wt- and rTGEV-7-infected tissues (Fig.
8A) that correlated with the damage observed by histopathology
(47). The number of granulocytes seemed to decrease at 4 dpi in
both infections (Fig. 8A), although the lung damage in rTGEV-7
infection was increased compared to the one observed at 1 dpi
(47). These data suggested that granulocytes were rapidly re-
cruited at the sites of infection, as expected. The contribution of
macrophages to tissue damage was analyzed by using the antibody
4E9/11 that specifically labeled porcine lysosomal associated
membrane protein 1 (LAMP-1, CD107a), which mainly detects
cells in an active phagocytosis state (59, 67). Therefore, this anti-
body allowed the simultaneous detection of both activated resi-
dent macrophages and circulating monocytes recruited into the
FIG 4 Host protein andmRNA levels in rTGEV-7 infection. Quantification of
porcine TNF (upper panels), CCL2 (middle panels), and IFN-
 (lower panels)
accumulation in mock-infected cells (white) or during rTGEV-wt (black) or
rTGEV-7 (gray) infections. At 16 hpi, mRNA accumulation was measured by
RT-qPCR (left), and protein accumulation wasmeasured by ELISA (right). Error
bars indicate the standard deviations from three independent experiments. ***,
P 0.001; **, P 0.01.
FIG 5 Expression of cytokines by PBMCs from infected animals. PBMCs from
rTGEV-wt (black)- or rTGEV-7 (gray)-infected animals, extracted at 0.5 and
3 dpi, were cultured and stimulatedwith TGEV. At 24 h after stimulation, total
RNAwas extracted, and the cytokinemRNA levelswere analyzed byRT-qPCR.
GUSB mRNA levels were used as endogenous control in all cases. Error bars
indicate the standard deviations from two different animals. ***,P 0.001; **,
P 0.01; *, P 0.05.
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site of infection, providing that they were subsequently activated.
Other porcine macrophage markers, such as CD163, CD68 and
CD172a, were tested. Unfortunately, the antibodies specific for
these markers did not work in paraffin-embedded lung sections.
An increased number of activated macrophages was observed in
rTGEV-7-infected lungs at 4 dpi compared to those infected
with rTGEV-wt (Fig. 8B). Although it was previously reported
that TGEV can replicate in alveolar macrophages (61), double-
labeled cells (4E9/11 TGEV) were not detected in the lung sec-
tions at any time point analyzed. It was previously observed that
rTGEV-7 titers in lung were higher than those of the rTGEV-wt
virus at early times postinfection (47). Therefore, the contribution
of differences in tissue infection levels to leukocyte recruitment
and activationwas a realistic possibility. To clarify this issue, gran-
ulocyte and macrophage recruitment and activation, during
rTGEV-wt and rTGEV-7 infections, were estimated relative to
FIG 6 Expression of cytokines in lungs from infected animals. Lung fragments
from rTGEV-wt (black)- or rTGEV-7 (gray)-infected animals were collected
at 1, 2, and 4 dpi. Total RNA was extracted, and the viral gRNA accumulation
and cytokine mRNA levels were analyzed by RT-qPCR. TNF (upper panel),
CCL2 (middle panel), and CCL5(lower panel) mRNA levels were determined
relative to the viral gRNA in all cases. In addition, the GUSBmRNA levels were
used as an endogenous control in all cases. Error bars indicate the standard
deviations from two different animals. ***, P 0.001; **, P 0.01; *, P 0.05.
r.u., relative units.
FIG 7 Cytokine levels in sera from infected animals. Quantification of porcine
CCL2 (upper panel) and TNF (lower panel) accumulation in sera frommock-
infected piglets (white) or animals infected with rTGEV-wt (black) or rT-
GEV-7 (gray). Cytokine accumulation was measured by ELISA at the indi-
cated times postinfection. Error bars indicate the standard deviations from
three independent experiments. **, P 0.01; *, P 0.05.
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tissue infection levels in each case. Granulocyte recruitment was
similar in both wild-type and mutant virus-infected tissues
(Fig. 9). In contrast, at 4 dpi rTGEV-7-infected tissues showed a
significant increase in macrophage recruitment and activation
compared to rTGEV-wt-infected tissues (Fig. 9). Altogether, these
data suggested that the enhancement of lung damage produced by
rTGEV-7 infection was, at least in part, due to the preferential
recruitment and activation ofmacrophages, most likely due to the
increased levels of proinflammatory cytokines such as TNF or
CCL2.
DISCUSSION
We have previously shown that an rTGEV lacking protein 7 ex-
pression was more virulent and caused increased pathology than
the parental virus (47). To analyze the potential mechanism un-
derlying this enhanced pathology, the patterns of gene expression
after infection by each of these viruses were analyzed using mi-
croarrays covering the complete porcine genome. A marked up-
regulation of proinflammatory cytokine mRNA expression was
observed in infections with the virus deficient in protein 7. The
identification of elevated TNF, CCL2, and IFN-
 confirmed the
increased proinflammatory pattern at the protein level. Further-
more, similar results were obtained in in vivo infections, indicat-
ing that the presence of protein 7 reduced inflammatory changes
after TGEV infection both in cell cultures and in vivo.
Viruses are good tools for understanding the molecular mech-
anisms modulating inflammation, especially signaling pathways
that increase disease severity. The increased inflammation ob-
served after rTGEV-7 infection, caused by an exacerbated innate
immune response and leading to an enhanced pathogenesis, was
also described for human viruses infecting the respiratory tract,
such as respiratory syncytial virus (RSV) or influenza virus. TGEV
is a virus with enteric and respiratory tropism. Lung and gut in-
fection by virulent TGEV caused significant inflammation in both
tissues, and animal death is mainly due to the severe unbalance of
Na and K ions caused by the clinical manifestation of the in-
fection (68). It is important to note that the work described here
was performed with the cell culture-adapted TGEV used in the
FIG 8 Leukocyte detection in lung sections from infected animals. Lung sections from noninfected (Mock) and rTGEV-wt (WT)- or rTGEV-7 (7)-infected
piglets, at 1 and 4 dpi, were labeled with a monoclonal antibody specific for granulocytes (A) or macrophages (B) (red) and a polyclonal antibody specific for
TGEV (green). Cell nuclei were labeled with DAPI (blue). Pictures were obtained by using confocal microscopy with a40 objective lens.
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previous study (47), which only displays respiratory tropism caus-
ing lung damage and no apparent gut infection. TGEV is a porcine
virus, and the work presented here has been performed using the
natural host, which is immunologically more similar to humans
(80%) than mice (10%) (69). Therefore, our findings might
be informative for the conserved pathways leading to increased
pathology both in pigs and humans.
TGEV protein 7 reduced the dsRNA triggered antiviral re-
sponse (47). As a consequence, rTGEV-7 infection caused en-
hanced cell death, cellular RNA degradation, and protein synthe-
sis shutoff (47). The results presented here were most likely not
conditioned by these effects, since bothmicroarray and RT-qPCR
analyses were performed using the same amount of total intracel-
lular RNA of equal quality, extracted from living cells attached to
the plate. In addition, microarray data normalization corrects any
differences in mRNA amount between samples, and in RT-qPCR
the mRNA levels always referred to the amount of GUSB that
correlated with the percentage of living cells. In the case of cyto-
kinemeasurements in the supernatants of infected cells, cell death
most likely did not significantly affect quantifications, since simi-
lar differences between rTGEV-wt and rTGEV-7 viruses were
obtained when intracellular protein extracts were used for ELISAs
(data not shown). In addition, up to a 20-fold increase in mRNA
accumulation led to an increase no more than 3.5-fold in protein
levels when rTGEV-wt and rTGEV-7 infections were compared
(Fig. 4). Similarly, differences up to 103-fold inmRNA levels led to
no more than 10-fold differences in protein accumulation, when
comparing mock-infected cells to rTGEV-wt-infected cells (Fig.
4). This result suggested that shutoff caused by the rTGEV-7
virus was not affecting cytokine measurements.
The infection of swine by rTGEV-7 virus caused higher lung
damage than that caused by rTGEV-wt (47). Neutrophils and
macrophages have been proposed to cause lung damage during
most cases of acute lung injury andARDS (70). Granulocytes were
recruited to the TGEV-infected lungs, both in the presence and in
absence of protein 7, suggesting that they play a role in TGEV-
induced inflammation. In vivo, rTGEV-7 infection caused an
increased expression of proinflammatory cytokines such as TNF,
CCL2, and CCL5, whose main function is macrophage recruit-
ment and activation (26, 71, 72). In addition, at least in vitro,
rTGEV-7 infection induced the expression of CD40 receptor
(Fig. 2B), which has been involved inmacrophage activation (73).
In agreement with these results, in the lungs from rTGEV-7-
infected animals, an increase in macrophage recruitment and ac-
tivation was observed compared to the rTGEV-wt-infected ani-
mals. In line with these data, MHV infection of CCL5 receptor
knockout mice causes a reduced pathology due to a decrease in
macrophage recruitment (74). In addition, it was recently re-
ported that coronavirus infection of transgenic mice expressing
CCL2 led to an enhanced pathology leading to death, caused by a
dysregulated immune response without effective virus clearance
(75). Similar observations were obtained after influenza virus in-
fection of CCL2 (CCR2	/	) or CCL5 (CCR5	/	) receptors
knockout mice (76). Lung pathology was reduced in influenza
virus-infected CCR2	/	 mice, since monocyte recruitment is se-
verely impaired in these animals (76). In contrast, CCR5	/	 in-
fected mice showed increased mortality associated with elevated
macrophage infiltration in the lungs due to an increased expres-
sion of CCL2 (76). The data obtained in the present work sug-
gested that macrophages were involved in the enhanced inflam-
mation produced during infection in the absence of protein 7 and
were in agreement with the role of CCL2 in the immunopathology
mediated by macrophage recruitment.
An exacerbated proinflammatory cytokine production and an
excessive immune cell recruitment leading to tissue destruction
contributing to virus caused pathology, similar to that observed
after rTGEV-7 infection, has been described for several viral in-
fections (77–79). This immunopathology, known as “cytokine
storm,” could be the cause for the extreme virulence of several
viruses, such as pandemic influenza virus H5N1 or SARS-CoV
(80). Once started, increased proinflammatory cytokines could
continue driving immunopathology progression, even in the ab-
sence of viral replication. In fact, lung damage in SARS-CoV-
infected patients persists after virus titer reduction, suggesting
that pathology is mainly caused by the immune response (81).
Similarly, in RSV infections, the severity of the infection has been
correlated with CCL2 and CCL5 expression (72). In addition, cel-
lular recruitment,mediated by cytokine expression, has been con-
sidered responsible for damaging both infected and uninfected
areas of the lung (26). In line with these observations, rTGEV-7
FIG 9 Quantification of the leukocyte/infection ratio in lung sections from
infected animals. The leukocyte signal (immunofluorescence red channel) was
estimated in lung sections from infected animals. The positive area for granu-
locytes (upper panel) or macrophages (lower panel) signal relative to the pos-
itive area for TGEV infection (immunofluorescence green channel) signal was
calculated using MetaMorph software. Error bars indicate the standard devi-
ations from 20 observed fields in 10 independent samples. ***, P 0.001. r.u.,
relative units.
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infection caused a “cytokine storm” that led to a progression in
lung damage (47).
In the absence of protein 7, an increased expression in IFN-
,
IFN-stimulated genes (ISGs), and proinflammatory genes was ob-
served. Similar upregulation of geneswas reported for viruseswith
mutations in virus-encoded IFN antagonists, such as influenza
virus with the mutated NS1 gene (82, 83). To date, virus-encoded
IFN antagonists were mainly analyzed in overexpression studies,
and the activity of only around half of these antagonists was dem-
onstrated in the context of viral infection (27). The IFN antagonist
activity of TGEV protein 7 decreasing IFN-
 production was
demonstrated here, in the context of viral infection, although
more studies are required to further determine the characteristics
and mechanism of IFN antagonism by protein 7.
As expected for a virus defective in an IFN antagonism path-
way, the rTGEV-7 mutant virus was more sensitive to IFN-
-
induced antiviral effects (data not shown). Nevertheless, the rT-
GEV-7 virus underwent efficient replication despite increased
IFN-
 production. This was explained by the amount of IFN-

produced by ST cells, being 103-fold lower than the minimal con-
centration required for decreasing TGEV replication (data not
shown). Most likely, this result was a consequence of the presence
of other virus-encoded IFN antagonists in both rTGEV-wt and
rTGEV-7 genomes.
We have previously shown that TGEV protein 7 limited RNase
L activation and eIF2 phosphorylation through its binding to
PP1 phosphatase (47). RNase L has been involved in the IFN re-
sponse, since cells deficient in this enzyme, infected with different
viruses, produce lower IFN-
 amounts than normal cells (23). It
was proposed that the RNA degradation products generated by
RNase L are recognized by RIG-I, acting as amplifiers of IFN pro-
duction (23). In fact, the direct implication of RNase L on IFN
production has been recently demonstrated using anMHV acces-
sory protein ns2mutant virus (24). In addition, PKRhas also been
recently involved in the amplification of innate immune response
through a translational control mechanism, dependent on eIF2
phosphorylation, leading to increased IFN-
 production and
NF-B activation (84). Therefore, the increased IFN-
 and pro-
inflammatory cytokines production observed during rTGEV-7
infection, in the absence of protein 7, could be explained in the
context of the previously proposed TGEVprotein 7mechanism of
action, highlighting the role of RNase L and eIF2 phosphoryla-
tion in innate immunity. The results presented here confirm the
role of CoV accessory genes in the modulation of innate immune
responses during infection. The tight regulation of deleterious in-
flammatory responses by virus-encoded proteins seems to modu-
late both virus and host survival.
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